Early research (Phase 1)Study completedNCT01560793
What this trial is testing
Safety and Immunogenicity of a Novel H5N1 Influenza Vaccine in Healthy Adults Age 18-49 Years
Who this might be right for
Influenza
VaxInnate Corporation 224
Showing 20 of 0 results